Abstract
Severe combined immunodeficiency (SCID) is a Primary Immune Deficiency that is under consideration for population-based newborn screening (NBS) by many NBS programs, and has recently been recommended for inclusion in the US uniform panel of newborn screening conditions. A marker of SCID, the T cell receptor excision circle (TREC), is detectable in the newborn dried blood spot using a unique molecular assay as a primary screen. The New England Newborn Screening Program developed and validated a multiplex TREC assay in which both the TREC analyte and an internal control are acquired from a single punch and run in the same reaction. Massachusetts then implemented a statewide pilot SCID NBS program. The authors describe the rationale for a pilot SCID NBS program, a comprehensive strategy for successful implementation, the screening test algorithm, the screening follow-up algorithm and preliminary experience based on statewide screening in the first year. The Massachusetts experience demonstrates that SCID NBS is a program that can be implemented on a population basis with reasonable rates of false positives.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Atkinson K, Zuckerman B, Sharfstein J, Levin D, Blatt RJR, Koh H (2001) A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep 116:122–131
Baker MW, Grossman WJ, Laessig RH et al (2009) Development of a routine newborn screening protocol for severe combined immunodeficiency. J Allergy Clin Immunol 124(3):522–527
Barrett MJ, Buckley RH, Schiff SE, Kidd PC, Ward PE (1988) Accelerated development of immunity following transplantation of maternal marrow stem cells into infants with severe combined immunodeficiency and transplacentally acquired lymphoid chimerism. Clin Exp Immunol 72(1):118–123
Buckley RH (2000) Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343:1313–1324
Buckley RH (2004) Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. Annu Rev Immunol 22:625–655
Buckley RH, Schiff RI, Schiff SE et al (1997) Human severe combined immunodeficiency: genetic, phenotypic, and functional diversity in one hundred eight infants. J Pediatr 130(3):378–387
Buckley R, Schiff SE, Schiff RI et al (1999) Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340(7):508–516
Centers for Disease Control and Prevention (2001) CDC National Workshop: Applying Genetic and Public Health Strategies to Primary Immunodeficiency Diseases, Atlanta, GA
Centers for Disease Control and Prevention (2004) Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Morb Mortal Wkly Rep 53(No. RR-1):1–29
Centers for Disease Control and Prevention (2010) Childhood Immunization Schedules for birth to 6 years old. Accessed January 20, 2010 <http://www.cdc.gov/vaccines/recs/schedules/downloads/child/2010/10_0-6yrs-schedule-pr.pdf>
Chan K, Puck JM (2005) Development of population-based newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol 115(2):391–398
Code of Massachusetts Regulations (2008): 105 CMR 270.000 Sections 270.001-011; Blood Screening of Newborns for Treatable Diseases and Disorders
Comeau AM (2007) Newborn Screening Expansion: Massachusetts Research Models Encompass Public Health Service Responsibility. In: Knoppers MB (ed) Genomics and Public Health: Socio-Ethical and Legal Perspectives. Martinus Nijhoff International, Leiden, pp 45–53
Comeau AM (2008a) Implementing SCID Newborn Screening with Multiplex Assays in an Integrated Program Approach. Centers for Disease Control and Prevention Grant # IUIEH000362
Comeau AM (2008b) Development and Validation of a Multiplex Assay for Identification of Infants with SCID. The 2008 APHL Newborn Screening and Genetic Testing Symposium, San Antonio, TX. Accessed January 20, 2010 http://www.aphl.org/profdev/conferences/proceedings/Documents/2008%20_APHL_NBS_and_Genetics_Testing_Symposium/054%20-%20Comeau%2010.pdf
Comeau AM, Levin D (2009) Population-based research within a public health system: two models for common rule compliance in the Massachusetts Newborn Screening Program. In: Bailey M, Murray T (eds) Ethics and newborn genetics screening: New technologies, new challenges. Johns Hopkins Press, Baltimore, pp 274–291
Douek DC, McFarland RD, Keiser PH et al (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690–695
Geha RS, Notarangelo LD, Cassanova JL et al (2007) Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J Allergy Clin Immunol 120(4):776–794
Health Resources and Services Administration, Centers for Disease Control and Prevention (2007) National Newborn Screening SCID Working group, San Francisco, CA
Howell RR (2008 January) Minutes, Thirteenth Meeting of the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Accessed December 21, 2009 http://www.hrsa.gov/heritabledisorderscommittee/meetings/2008january/minutes0108.htm
Howell RR (2009 February) Minutes, Seventeenth Meeting of the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Accessed December 21, 2009 http://www.hrsa.gov/heritabledisorderscommittee/meetings/2009february/default.htm
Howell RR (2010 February) Correspondence. Twentieth Meeting of the Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Accessed March 26, 2010 http://www.hrsa.gov/heritabledisorderscommittee/meetings/default.htm
Jeffery Modell Foundation, Centers for Disease Control and Prevention, National Newborn Screening and Genetic Resource Center (2006) National Workshop on Newborn Screening for SCID. Atlanta, GA
Lipstein E, Knapp AA, Perrin JM (2009) Evidence Review: Severe Combined Immunodeficiency (SCID). Prepared for Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. Retrieved from http://www.hrsa.gov/heritabledisorderscommittee/reports/evidencereviewSCID/default.htm. Accessed December 21, 2009
Muller SM, Ege M, Pottharst A, Schultz AS, Schwartz K, Friedrich W (2001) Transplacentally acquired maternal T lymphocytes in severe combined immunodeficiency: a study of 121 patients. Blood 98(6):1847–1851
Myers LA, Patel DD, Puck JM, Buckley RH (2002) Hematopoietic stem cell transplantation for severe 7combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 99(3):872–878
National Institute of Health (2002) NIH National Workshop to Develop Newborn Screening Technology for SCID, Bethesda, MD
Qiao H, Clark HF, DiVietro M, Riepenhoff-Talty M (2004) A comparison of the effects of oral inoculation with Rotashield and pentavalent reassortant rotavirus vaccine (WC3-PV) on suckling CB17scid mice. J Gen Virol 85:2245–2253
Tuerck J, Dhondt JL, King P et al (2006) Newborn screening follow up: approved guideline. CLSI document I/LA27-A [ISBN 1-56238-606-9]
Watson MS, Mann, MY, Lloyd-Puryear, Rinaldo, P (2006) Newborn screening: toward a uniform screening panel and system. Genet Med Suppl 1:1S-252S
Wilson IG (1997) Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol 63(10):3741–3751
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Rodney Pollitt
Competing interest: None declared.
Rights and permissions
About this article
Cite this article
Comeau, A.M., Hale, J.E., Pai, SY. et al. Guidelines for implementation of population-based newborn screening for severe combined immunodeficiency. J Inherit Metab Dis 33 (Suppl 2), 273–281 (2010). https://doi.org/10.1007/s10545-010-9103-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-010-9103-9